Private Capital Advisors’s Boston Scientific BSX Stock Holding History

Private Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,497	Closed	-$244K	–	76
2025 Q3	$244K	Hold	2,497	–	–	0.03%	73
2025 Q2	$268K	Hold	2,497	–	–	0.03%	72
2025 Q1	$252K	Hold	2,497	–	–	0.03%	67
2024 Q4	$223K	Hold	2,497	–	–	0.03%	68
2024 Q3	$209K	Buy	+2,497	New	+$197K	0.02%	73
2022 Q2	–	Sell	-43,806	Closed	-$1.94M	–	96
2022 Q1	$1.94M	Buy	+43,806	New	+$1.9M	0.28%	48

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Private Capital Advisors's BSX Position: Q4 2025 in Review

Private Capital Advisors sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,497 shares — an estimated $244K sold.

Private Capital Advisors first reported a position in BSX in Q1 2022 and held it in 6 quarters. The position peaked at $1.94M in Q1 2022. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Private Capital Advisors reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Private Capital Advisors sold 2,497 Boston Scientific shares in Q4 2025, an estimated $244K.
Private Capital Advisors first reported a position in Boston Scientific in Q1 2022 and held it in 6 quarters.
Private Capital Advisors's Boston Scientific position peaked at $1.94M in Q1 2022.
1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Private Capital Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.